Healthcare - Biotechnology - NASDAQ - US
$ 5.105
-8.84 %
$ 854 M
Market Cap
-2.03
P/E
BALANCE SHEET
844 M
ASSETS
92 M
LIABILITIES
752 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Relay Therapeutics, Inc.
| Current Assets | 770 M |
| Cash & Short-Term Investments | 750 M |
| Receivables | 0 |
| Other Current Assets | 20 M |
| Non-Current Assets | 73.9 M |
| Long-Term Investments | 0 |
| PP&E | 68.9 M |
| Other Non-Current Assets | 5.01 M |
| Current Liabilities | 30.3 M |
| Accounts Payable | 9.21 M |
| Short-Term Debt | 9.93 M |
| Other Current Liabilities | 11.1 M |
| Non-Current Liabilities | 61.7 M |
| Long-Term Debt | 48.5 M |
| Other Non-Current Liabilities | 13.2 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 143.7 | 998.9 | 958.1 | 447.6 | 42.0 | 421.5 |
| Short Term Investments | 606.4 | 847.1 | 678.0 | 230.4 | 313.9 | 0 |
| Receivables | 0 | 5.2 | 4.9 | 82.7 | 0 | 0 |
| Inventory | 0 | 12.1 | (682.5) | (238.1) | 0 | 0 |
| Other Current Assets | 20.0 | 15.4 | 13.2 | 9.4 | 4.7 | 2.6 |
| Total Current Assets | 770.1 | 1 019.5 | 976.2 | 770.1 | 360.5 | 424.1 |
| PP&E | 68.9 | 75.4 | 27.3 | 28.8 | 31.7 | 3.6 |
| Intangible Assets | 2.3 | 2.3 | 2.3 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 2.6 | 2.6 | 0.9 | 0.9 | 0.9 |
| Other Long Term Assets | 2.7 | 2.6 | 2.6 | 22 K | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 844.0 | 1 099.8 | 1 008.4 | 799.8 | 393.1 | 428.6 |
| LIABILITIES | ||||||
| Accounts Payable | 9.2 | 10.6 | 8.3 | 6.4 | 7.0 | 4.7 |
| Short Term Debt | 9.9 | 8.6 | 3.7 | 3.0 | 1.2 | 0.2 |
| Other Current Liabilities | 11.1 | 44.6 | 12.1 | 4.2 | 3.7 | 2.0 |
| Total Current Liabilities | 30.3 | 63.7 | 24.3 | 13.6 | 12.0 | 6.9 |
| Long Term Debt | 48.5 | 53.5 | 21.1 | 22.9 | 23.6 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 13.2 | 32.4 | 65.3 | 3 K | 537.9 | 532.7 |
| Total Liabilities | 92.0 | 149.6 | 110.6 | 36.5 | 573.5 | 539.5 |
| EQUITY | ||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 90 K | 4 K | 3 K |
| Retained Earnings | (1 400.6) | (1 058.6) | (768.1) | (404.2) | (189.5) | (114.2) |
| Other Accumulative Comprehensive Income/Loss | (0.2) | (10.4) | (1.1) | 64 K | 0.3 | (4.6) |
| Total Equity | 752.0 | 950.2 | 897.8 | 763.3 | (180.4) | (110.9) |
| Total Liabilities and Equity | 844.0 | 1 099.8 | 1 008.4 | 799.8 | 393.1 | 428.6 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 122.6 | 112.2 | 95.1 | 42.6 | 4.3 | 2.5 |